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complex series of biochemical events that result in the release of inﬂammatory mediators. The
essential role of the protein tyrosine kinase Syk has been appreciated for some time, and newer
results have deﬁned the mechanism of its activation. The use of siRNA has deﬁned the relative con-
tribution of Syk, Fyn and Gab2 to signaling and has made possible a screening study to identify pre-
viously unrecognized molecules that are involved in these pathways.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
The activation of mast cells or basophils initiates a series of bio-
chemical events which result in the release of biologically active
mediators that cause allergic reactions. A major mechanism for
the stimulation of these cells is the interaction of antigen with
the IgE bound to high afﬁnity IgE receptor (FceRI) on the cell sur-
face. A series of biochemical events then result in the release of
preformed mediators from granules and the generation of newly
synthesized mediators.
This review ﬁrst summarizes the current model for the FceRI-
induced signaling based on studies from our and other groups
[1–4]; it then reviews studies on the important role of the tyrosine
kinase Syk in these reactions, and then recent studies from our lab-
oratory on these processes.
2. Model of mast cell activation
FceRI is a member of the immunoreceptor family that includes
the B cell receptor, T cell receptor and immunoglobulin receptors.
These receptors have subunits which contain a sequence named
the immunoreceptor tyrosine-based activation motif (ITAM) that
has two tyrosine residues separated by 6–8 amino acid residues.
FceRI is a tetrameric formed by the complex abc2 chains (Fig. 1).lf of the Federation of European BiThe a-chain binds the Fc portion of IgE at ratio of 1:1 while the
b- and c-chains contain ITAMs in their cytoplasmic domains. Be-
cause FceRI has no intrinsic enzymatic activity, the activation of
non-receptor protein tyrosine kinases are essential for cell activa-
tion. Aggregation of FceRI results in phosphorylation of the two
tyrosine residues within the ITAMs by Lyn, or another member of
the Src family of tyrosine kinases that associate with the receptor.
Phosphorylated ITAM then serves as a docking site for Syk; this
binding of Syk through its SH2 domains results in a conformational
change of Syk which increases its enzymatic activity.
Once activated, Syk is tyrosine phosphorylated predominantly
due to autophosphorylation [5–7] and leads to downstream prop-
agation of signals. Syk then tyrosine phosphorylates the adaptors
LAT1 and LAT2 (NTAL) which are membrane proteins, activates
the PI3K pathway and the protein tyrosine kinase BTK. Phosphory-
lated LAT functions as a scaffold for multimolecular signaling com-
plexes that include cytosolic adaptors, such as Gads, Grb2, SLP-76,
and Shc; guanosine triphosphate exchangers, including Sos and
Vav1; and the enzymes phospholipase Cc1(PLC) and PLCc2. Phos-
pholipase Cc activated through these pathways together with con-
tributions by the protein tyrosine kinase Btk, and PI3K then
hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) in the
plasma membrane to produce the second messengers diacylglyc-
erol (DAG) and inositol 1,4,5-trisphosphate (IP3) which, respec-
tively, result in the activation of protein kinase C (PKC) and the
rise in intracellular calcium [Ca2+]i [1]. Binding of IP3 to IP3 recep-
tors (IP3R) in the ER (endoplasmic reticulum) membrane, causesochemical Societies.
Fig. 1. Model depicting major molecules and events in mast cell activation. Antigen binding to IgE cross-links two FceRI leading to Lyn phosphorylating the tyrosines in the
ITAMs of the b and c-subunits of the receptor. Syk kinase is recruited and activated by binding to the phosphorylated ITAM of the c subunit; the activated Syk
autophosphorylates and activates downstream signaling which includes phosphorylation of Btk, PI3K, LAT, SLP-76 and PLCc. Multimolecular complexes form on LAT which
includes Gads, SLP-76, PLCc and Vav. The activated PLCc hydrolyzes PI(4,5)P2 to form DAG and IP3. The IP3 activates the IP3-receptor on the ER releasing calcium, the calcium
sensor Stim1 then interacts with the Orai1 membrane protein opening the CRAC channels allowing the increase in intracellular calcium. DAG activates PKC and also interacts
with calmodulin to activate calcineurin leading to NFAT translocation into the nucleus. The activation of GTPases lead to MAP kinase activation. These pathways lead to
degranulation, release of leukotrienes and cytokine synthesis.
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free Ca2+ concentration in the ER. This results in only a small and
transient increase in [Ca2+]i that is not sufﬁcient for most cellular
responses. The depletion of ER Ca2+ stores results in Ca2+ inﬂux
across the plasma membrane by a mechanism that has been called
store-operated calcium entry (SOCE). Although the electrophysiol-
ogy of these channels, termed CRAC (calcium release-activated cal-
cium), were well known, their molecular identity was only recently
determined [8,9]. Two molecules, Stim1 and Orai1 were identiﬁed
as being responsible for this store-operated calcium entry in im-
mune cells; Orai1 is the pore subunit of the CRAC channel while
Stim1 is ER Ca2+ sensor that sense ER Ca2+ concentration. The
depletion of calcium in the ER induces Stim1 formation of multi-
mers in the ER membrane which move to sites of ER-plasma mem-
brane apposition and interact directly with Orai1 channels. A
number of intracellular signals including the activation of several
members of the protein kinase C family, phospholipase D and
sphingosine kinases are thought to play a role in subsequent
events [10]. These early events activate the small GTPases such
as Rac, Ras and Rho resulting in the stimulation of the ERK, JNK
and p38 MAP kinase pathways. The MAP kinases are important sig-
naling mediators between the cytosol and the nucleus that regu-
late a variety of transcription factors. Further the increase in
[Ca2+]i with the participation of SNARE complex of proteins allow
granular fusion and release of their contents.
The increase in intracellular calcium concentration also acti-
vates the Ca2+/calmodulin-dependent serine phosphatase calcineu-rin. Calcineurin dephosphorylates the nuclear factor for T cell
activation (NFAT) which exposes NFAT nuclear-localization signals.
Once in the nucleus, NFAT regulates the transcription of several
cytokine genes. Transcriptions of other pro-inﬂammatory media-
tors are regulated by NFjB proteins which are transcription factors
retained in the cytoplasm by binding to the inhibitor IjB. FceRI
stimulation leads to phosphorylation, and degradation of IjB
which allows the release and nuclear translocation of the NFjB
proteins. Protein kinase Cb (PKCb), CARMA1, Bcl10, and MALT1
are other proteins involved in this pathway. Activation of the NFAT
and NFjB transcription factors and the MAP kinases then results in
the synthesis of several cytokines. Another substrate of PKC and
the MAP-kinases is cytoplasmic phospholipase A2 which releases
arachidonic acid that is metabolized by the cycloxygenase or the
lipoxygenase pathways to form the inﬂammatory mediators, pros-
taglandins and leukotrienes.
Receptor aggregation also activates and recruits negative regu-
lators which limit the intensity and duration of the positive signals.
Among these are c-Cbl, which ubiquinates signaling molecules,
PTEN and SHIP both of which hydrolyze PIP3 products of PI3K
and SHP-1 that can dephosphorylate signaling molecules. Interest-
ingly, the tyrosine phosphorylation of these are upstream of Syk
[11]. Other negative signals are generated by recruitment of nega-
tive signaling molecules such as SHIP or SHP to the membrane by
ITIM-bearing receptors (e.g., FccRIIB). The tyrosine in the ITIM is
phosphorylated during the activation steps by Lyn then recruits
inhibitory effectors such as SHIP, SHP-1 or SHP-2. In some but
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tion of the two receptors (such as FceRI and the negative receptor).
3. Syk regulating FceRI function
Syk and ZAP-70 are members of a non-receptor tyrosine kinase
family one or both of which are expressed in the cytoplasm of
hematopoietic cells [12]. Structurally Syk/ZAP-70 consists of two
Src-homology 2 domains (SH2) and a kinase domain followed by
a short COOH-terminal extension (tail). The interdomain A is lo-
cated between the NH2-terminal SH2 (SH2-N) and COOH-terminal
SH2 (SH2-C), while interdomain B or linker region is between the
SH2-C and the kinase domains [12,13].
Syk/ mice have high rates of perinatal lethality, and exhibit
cardiovascular, immune, and hematopoietic defects showing that
this kinase is required for development and function of various tis-
sues. Although several tyrosine kinases have been implicated in
FceRI-mediated signaling, only the absence of Syk results in com-
plete loss of degranulation and release of cytokines [14]. Syk-neg-
ative cells are defective in most of the signaling events that occur
after FceRI stimulation; except for the tyrosine phosphorylation
of submits of the receptor and the negative regulatory proteins
SHIP1, SHP1 and SHP2. Syk/ mast cells also are unable to activate
NFAT or NFjB [15,16]; but transfection of these cells with Syk
reconstitutes their activation. In addition, treatment of bone mar-
row mast cells (BMMC) with siRNA targeted to Syk efﬁciently de-
creases receptor-induced cell activation [17].
Phosphorylated ITAM serves as the docking site for the two SH2
domains of Syk with an anti-parallel binding orientation: the SH2-
N of Syk binds to the COOH-terminal phospho-tyrosine of the ITAM
while the SH2-C binds to the NH2-terminal phospho-tyrosine
[18,19]. Experiments using peptides corresponding to the b- and
c-ITAM of FceRI showed that Syk binds preferentially to the
biphosphorylated c-ITAM [18]. Although this association requires
both SH2 domains of Syk, the SH2-C binds stronger to the phos-
phorylated c-ITAM than the SH2-N [20].
The binding of Syk to the phosphorylated ITAM results in con-
formational changes of Syk molecule by exposing its COOH-termi-
nal region [21]. Structural studies of ZAP-70 suggest an auto-
inhibitory state for Syk family proteins where, during the inactive
state, the COOH-terminal region interacts with the inter-SH2 do-
main by a hydrogen-bonding network. This stabilizes the auto-
inhibitory structure of the enzyme [22]. The binding of Syk to the
phosphorylated ITAM disrupts the COOH-terminal/SH2-interdo-
main interactions which ‘‘opens” the molecule resulting in confor-
mational changes which leads to Syk activation [16].
Tyrosine phosphorylation of Syk after receptor aggregation is
due to mostly autophosphorylation with some contribution by
other tyrosine kinases [5]. There are ten tyrosines that are auto-
phosphorylated in Syk in vitro and several of these are also found
to be phosphorylated in vivo after cell activation [23,24]. Such
phosphorylations can regulate Syk function and also generate po-
tential docking sites for other molecules. One of these phosphoty-
rosines, Tyr-130, located in the inter-SH2 domain regulates Syk
binding to phosphorylated ITAM; phosphorylation of Try-130
inhibits Syk binding while Y130F mutation enhances this associa-
tion [25]. Phosphorylation of other tyrosines in Syk may also play
a role in regulating ITAM binding including tyrosines in the linker
region [16,26].
The linker region plays an important role in regulating Syk func-
tion. An alternatively spliced form of Syk, termed SykB, lacks a 23
amino acid sequence in the linker domain; although both isoforms
are expressed in mast cells, Syk is more efﬁcient than SykB in
immunoreceptor signaling [27]. There are three conserved tyro-
sines in the linker region of both Syk and ZAP-70 (Tyr-317,Tyr-342 and Tyr-346). Substitution of Tyr-317 with Phe enhances
Syk-mediated signaling in mast cells and increases its kinase activ-
ity [28]. Phosphorylation of Tyr-317 also creates a binding site for
Cbl family proteins which are negative regulators of tyrosine ki-
nases; c-Cbl mediates ubiquitination of both Syk and FceRI after
antigen activation [29]. Furthermore, studies with c-Cbl and Cbl-
b deﬁcient cells indicate that Cbl-b functions as a negative regula-
tor of FceRI-induced degranulation while c-Cbl is more involved in
MAP kinase regulation [30]. Analysis of the other two tyrosines
(Tyr-342 and Tyr-346) indicate that phosphorylation of Tyr-342
is required for Syk-mediated phosphorylation of SLP-76, LAT and
PLC-c2, calcium mobilization and mast cell degranulation [26].
This can be as a result of decreased kinase activity and reduced
binding of Syk to phosphorylated c-ITAM when the Tyr-342 was
mutated to Phe. Interestingly, Tyr-346 is minimally phosphory-
lated after receptor stimulation and its substitution with Phe has
minimal effects on receptor-mediated mast cell degranulation.
In the kinase domain of Syk the two adjacent tyrosines Tyr-519/
Tyr-520, in the activation loop of the enzyme, are phosphorylated
after Syk activation both in vitro and in cells. Substitution of these
with Phe reduces signaling and degranulation in mast cells,
although it does not cause signiﬁcant changes on Syk kinase activ-
ity [31]. Interestingly, the binding of anti-ganglioside antibody to
mast cells increased Syk tyrosine phosphorylation but not hista-
mine release or phosphorylation of the activation loop tyrosines
[5]. This demonstrates that phosphorylation of Tyr-519 and Tyr-
520 is required for Syk function in vivo.
The COOH-terminal region of Syk has three conserved tyro-
sines (Tyr-623, Tyr-624 and Tyr-625) the last two of which are
also conserved in human ZAP-70. Tyr-624 and Tyr-625 are phos-
phorylated in both Syk and ZAP-70 by autophosphorylation or
following receptor stimulation [23,32]. Mutation of these three
Tyr to Phe disrupts the auto-inhibitory state of Syk which allows
it to be more tyrosine phosphorylated by another tyrosine kinase
in cells which activates Syk and results in autophosphorylation.
Without such phosphorylation by another tyrosine kinase, these
mutations result in Syk that has very low enzymatic activity
and capacity for autophosphorylation. In immunoreceptor signal-
ing, Syk alone is sufﬁcient to propagate downstream signaling,
whereas ZAP-70 requires the additional activity of another tyro-
sine kinase, Lck. Therefore mutation of these tyrosines results in
Syk which functionally is more similar to ZAP-70 in its require-
ment for another tyrosine kinase for activation. In mast cells this
mutated Syk is less efﬁcient in FceRI signaling because of de-
creased binding to phosphorylated ITAM independent of phos-
phorylation of Tyr-130. Together with the decreased kinase
activity, this leads to reduced mast cell degranulation, and de-
creased phosphorylation of MAP kinases, and lower activation
of NFAT and NFjB [16].
The present model for activation of Syk is shown in Fig. 2. Struc-
tural studies of ZAP-70 suggest that this family of kinases has an
auto-inhibitory state where there are interactions of Tyr in the tail
with both the kinase and the inter-SH2 domains. The globular rep-
resentation of Syk shows the molecule in its auto-inhibitory state
with the COOH-terminal tail interacting with the kinase and in-
ter-SH2 domains thereby contributing to keeping the molecule in
a closed conformation. The binding of Syk to the phosphorylated
ITAM results in a conformational change that exposes the COOH-
terminal tail region. This leads to the phosphorylation of the two
tyrosines (Tyr-624 and Tyr-625), which then keeps the molecule
in an open conformation allowing for further phosphorylation of
other tyrosine residues on Syk both by other tyrosine kinases but
mostly by autophosphorylation. Therefore, the phosphorylation
of Tyr-624 and Tyr-625 are important for the activation and regu-
lation of the activity of Syk.
Fig. 2. Syk activation. The globular representation of Syk shows the molecule in its auto-inhibitory state with the COOH-terminal tail interacting with the inter-SH2 domains
thereby contributing to keeping the molecule in a closed conformation. The binding of Syk to the phosphorylated ITAM results in a conformational change that exposes the
COOH-terminal region. This leads to the phosphorylation of two tyrosines in the tail, which then keeps the molecule in an open conformation allowing for further
phosphorylation of other tyrosine residues mostly by autophosphorylation, although there also could be contributions by other tyrosine kinases. Phosphorylation of Tyr-130
in the inter-SH2 domain results in Syk dissociating from the ITAM. Note all residue designations are for rat Syk, NCBI Reference Sequence NM_012758.1.
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Studies with Fyn and Gab2 deﬁcient cells suggest a role for
these proteins in signaling from FceRI. Although Lyn is thought
to be the enzyme that phosphorylates the tyrosine residues in
ITAMs of the b and c subunits [33], BMMC from Lyn/ mice have
normal or enhanced FceRI-induced degranulation, suggesting that
other tyrosine kinases such as Fyn could substitute for Lyn [34].
Fyn is activated following IgE-FceRI stimulation and its tyrosine
phosphorylation is increased in Lyn/ cells. In BMMC from Fyn
deﬁcient mice, there is decreased FceRI-induced PI3K activation
with reduced activation of JNK and p38 MAPKs, and of the tran-
scription factor NFjB; these changes parallel decreases in degran-
ulation, release of leukotrienes and generation of cytokines [35]. In
Fyn/ BMMC there is decreased tyrosine phosphorylation of Gab2
suggesting an interaction between Fyn and this adaptor protein
[36–38]. Gab2 is tyrosine phosphorylated after FceRI stimulation
downstream of Syk and has potential binding sites for signaling
molecules such as Grb2, SHP2, p85 subunit of PI3K and Shc. BMMC
from Gab2/ mice have decreased FceRI-induced PI3K activation,
reduced tyrosine phosphorylation of phospholipase Cc1, Akt and
JNK resulting in reduced degranulation and cytokine generation
[17]. Gab2 may also regulate granule translocation during degran-
ulation through a calcium-independent mechanism that also in-
volves Fyn and the small GTPase RhoA.
Experiments using transient transfections with small interfer-
ence RNA (siRNA) targeting Syk, Fyn or Gab2 indicate that de-
creased expressions of these proteins have distinct consequences
on FceRI-mediated mast cell signaling [15]. The siRNA treatment
efﬁciently decreases the expression of these proteins by more than
80%. For Syk there is a good correlation between the reduction in
protein expression and the decrease in the FceRI-mediated imme-
diate, late cellular responses and signaling events; degranulation
and TNF-a release, activation of NFjB and NFAT, as well as Akt
phosphorylation are all signiﬁcantly reduced. In contrast, compara-
ble decrease in Fyn expression has little or no effects on degranu-
lation, cytokine release and the same signaling events. Thedecreased expression of Fyn did not change the FceRI-induced
phosphorylation of Gab2 at two sites (Ser-159 and Tyr-452) that
are important for signaling by this protein. The reduced expression
of Gab2 but not Fyn decreases the receptor-induced PI3K activa-
tion, conﬁrming the role of Gab2 in regulating PI3K. The decreased
PI3K activation results in reduced phosphorylation of the MAPK
p38 and JNK, as well as reduced NFAT activation with a decrease
in TNF-a release but minimal changes in degranulation. The results
were very similar in BMMC and two different mouse mast cell
lines, one of which is growth factor dependent strongly suggesting
that these changes were due to the applied siRNA treatment. These
ﬁndings indicate that Fyn does not appear to play a major role in
IgE-mediated mast cell responses whereas Gab2 has a role in the
generation of cytokines.
The results of siRNA-induced decrease in expression of Fyn and
Gab2 are different than those with BMMC derived from mice with
knockout of the same proteins. The amount of a protein required
for signaling in these pathways may be in such excess that even
>80% decrease in expression as was achieved in these experiments
will not be a limiting factor in signal transduction. However, what-
ever the reason these observations have important implications for
pharmacological modulation of the activity of these molecules:
inhibitors of Syk would be effective in reducing both early and late
responses, while those that act on Gab2 would be effective on late
responses. In contrast, inhibition of Fyn would be ineffective in reg-
ulating mast cell responses.
5. Single cell analysis of mast cell responses
The FceRI-induced late mast cell responses was analyzed at a
single cell basis using an RBL-2H3 cell line transfected with a re-
porter plasmid containing three tandem NFAT binding sites fused
to enhanced green ﬂuorescent protein. Surprisingly, with this sen-
sitive detection system, there is activation of IgE sensitized cells at
concentrations of antigen which are as much as 10-fold lower than
was detected by degranulation. There are also differences in
signaling pathways leading to degranulation compared to
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and degranulation required Syk and calcineurin. However inhibi-
tors of the PI3K pathway block degranulation but do not decrease
NFAT activation [39,40]. Studies of the FceRI-induced increase in
intracellular calcium and the decrease in response with inhibitors
indicated that NFAT was activated at lower intracellular signals
compared to degranulation. Therefore, FceRI activation can result
in nuclear signals in the absence of the release of mediators. These
ﬁndings can explain some biological functions of mast cells that do
not correlate or require release of inﬂammatory mediators which
could occur due to contact with low concentrations of antigen.
The generation of nuclear signals would then regulate mast cell
survival, growth and differentiation.
6. FceRI-induced morphological and cytoskeletal changes
depend on Syk
Aggregation of FceRI in RBL-2H3 cells results in transformation
of the cell surface topography from ﬁnely microvillous to highly
folded or plicated, increases cell spreading and ﬂuid pinocytosis
with redistribution of actin [40,41]. These morphological changesFig. 3. The FceRI-induced morphological changes in mast cells require Syk. RBL-
2H3 (Syk+), TB1A2 (Syk), and the Syk transfected 3A5 cell line were cultured with
antigen speciﬁc IgE, washed and then either incubated with medium alone (A, C and
E) or activated with antigen (B, D and F). After 20 min the cells were prepared for
scanning electron microscopy. The nonstimulated RBL-2H3 cells are spindle-shaped
with their surface covered with small short microvilli (A); FceRI activation induced
cell spreading and transformed the cell surface to a lamellar topography with deep
folds and rufﬂes (B). The Syk-negative variant are less spindle-shaped and more
round and transfection of Syk into these cells did not change their appearance (C
and E). FceRI aggregation did not induce any morphological changes in the Syk-
negative cells (D) while these receptor-induced morphological changes are recon-
stituted by transfection of Syk (F).parallel mediator release. The receptor-induced morphological
changes and redistribution of actin are also observed in the ab-
sence of extracellular calcium suggesting that they are very early
events, independent of the major inﬂux of calcium [42] although
they are inhibited by the addition of a chelating agent such as EGTA
or EDTA [43]. Even in the absence of extracellular calcium there is
the transient increase in intracellular calcium that is due to the re-
lease of calcium from the ER. However, experiments with Syk ki-
nase inhibitors as well as Syk-negative cells indicate that the
FceRI-induced morphological/cytoskeletal changes are down-
stream of Syk. In Syk-negative cells FceRI-aggregation does not in-
duce increased tyrosine phosphorylation of the cytoskeletal
protein paxillin and the focal adhesion kinases FAK and Pyk2
[44,45]. Similarly tyrosine phosphorylation of Vav which regulates
GTP/GDP exchange activity for members of the Rho/Rac family of
GTP-binding proteins, Ras-GTPase activating protein and MAP ki-
nases are absent in Syk-negative cells. Transfection of Syk reconsti-
tutes these phosphorylations. Syk is also essential for the surface
topographical changes, cell spreading and redistribution of F-actin
(Fig. 3). Therefore, these biochemical and morphological changes
induced by FceRI aggregation are all downstream of Syk.7. siRNA screens to identify molecules that regulate FceRI-
stimulated signaling
Protein tyrosine phosphorylation is one of the earliest detect-
able events after FceRI aggregation and plays an essential role in
this signal transduction pathway [46]. There is also phosphoryla-
tion on other residues such as Ser/Thr and also of lipids all of which
are critical for signal transduction in cells. The extent of these
receptor induced-phosphorylations is regulated by the balance be-
tween protein kinases and phosphatases. As described in previous
sections, several kinases are responsible for these cellular re-
sponses. However, there is only limited information about the role
of protein phosphatases in the IgE-receptor induced pathways. So
far studies of phosphatases have been restricted to several well
characterized phosphatases, such as SHP1, SHP2, SHIP1, SHIP2,
and PTEN. The role of suchmolecules has been established by using
inhibitors or cell lines that are deﬁcient in one of these molecules.
Such cells are usually derived from either in vitro selection of
established cell lines or from genetically modiﬁed mice that lack
those molecules. Genome sequencing has predicted the presence
of many phosphatases about which there is little or no other infor-
mation. The development of siRNA technology has made it possible
to perform genetic screens in mammalian cell lines to determine
the function of such phosphatases, although such screening has
not been commonly applied to complex pathways such as degran-
ulation induced by antigen-receptor signaling. This siRNA ap-
proach is also challenging as differentiated immune cells are
notoriously difﬁcult to transfect. After testing different mast cell
lines and delivery systems a protocol suitable for a large-scale
screen was developed that yielded more than 80% transfection efﬁ-
ciency in the mouse mast cell line MMC-1 without affecting cell
survival or function. In control experiments Syk siRNA dramatically
decreased targeted protein expression with a comparable reduc-
tion in the FceRI-initiated mast cell degranulation. Compared to
stably transfected cell lines, this transient transfection system is
suitable for large scale screening in immortalized or primary cell
lines and it also eliminates the possibility of clonal variation. This
siRNA approach therefore, appears to be highly practical for large
scale screening to identify molecules in the signaling pathway
when combined with a speciﬁc assay, such as measurement of
the b-hexosaminidase release [46].
This siRNA screening approach was used to identify phospha-
tase genes that are involved in FceRI-stimulated degranulation by
Fig. 4. The comparisons of targeting Syk, PTEN and SHIP-1 in MMC-1 and BMMC.
The mouse mast cells line (MMC-1), or Bone Marrow Derived Mast Cells (BMMC)
were transfected with siRNA for Syk (A), PTEN (B) or SHIP-1 (C). Control cells were
transfected with scrambled siRNA ‘‘C”. The cells were sensitized and then
stimulated with antigen after 24, 48 and 72 h. The antigen-induced b-hexosamin-
idase release is expressed as the fraction of that in controls. The lysates of the cell
pellets were analyzed by immunoblotting with the indicated antibodies using the
anti-FceRIb as a loading control. ‘‘C” for scrambled siRNA controls, ‘‘E” experimental
siRNA.
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phosphatases. Out of 198 targets, 10 enhanced and seven inhibited
FceRI-induced degranulation in the MMC-1 mouse mast cell line.
The majority of the hits were poorly characterized molecules that
on the basis of their sequence had been classiﬁed as protein tyro-
sine, serine or dual speciﬁc phosphatases. However, there were
also some well characterized proteins, for example the siRNA that
targeted both the regulatory (Ppp3r1) and the catalytic (Ppp3cc)
subunit of calcineurin and PTEN (Pten) inhibited degranulation.
For seven of the strongest hits, four different siRNAs per target
were tested, and at least two out of the four single siRNA per target
had similar effects as the pool suggesting that these were true hits.
Bone marrow derived mast cells from normal mice further vali-
dated these results for six deﬁnite positive results; except for Pten,
all the other six positive hits including Inpp5b, Ppp3r1, Mtmr4,
Ptpn4, Ptpn9, and Ptpn14 had similar effects on FceRI-induced mast
cell degranulation in both MMC-1 and BMMC cells.
Among the positives, Pten knockdown had the opposite effect in
MMC-1 and BMMC; it strongly inhibited FceRI-induced b-hexosa-
minidase release in MMC-1 cells, while it slightly enhanced it in
BMMC (Fig. 4). In both cell types immunoblotting conﬁrmed the
speciﬁc knockdown of PTEN by siRNA. PTEN is a negative regulator
of the PI3K pathway by dephosphorylating phosphatidylinositol
phosphate (PI) at the 30 position. The disparity in degranulation re-
sponses due to decreased Pten expression between MMC-1 and
BMMC is probably due to a difference in the status of PI3K activa-
tion in the two cell types; the MMC-1 cells have a high basal PI3K
activity. Another negative regulator of the PI3K pathway is SHIP-1
that hydrolyzes PI-3,4,5-triphosphate at the 5’position. We there-
fore, compared the response on the MMC-1 and BMMC to the de-
creased expression of SHIP-1 (Fig. 4C). Although SHIP-1 is well
known to be a negative regulator of degranulation, decreased
expression enhanced release only in the BMMC. These data indi-
cate that the balance between PI(4,5)P2 and PI(3,4,5)P3 is different
in the MMC-1 and BMMC and show the importance of conﬁrming
siRNA screening results with primary cells.
The siRNA screen also identiﬁed the calcium-dependent serine/
threonine protein phosphatase calcineurin as a regulator of
degranulation in mast cells; knockdown of either its regulatory
subunit, (Ppp3r1) or catalytic subunit (PPP3CC) inhibited degranu-
lation in MMC-1 cells. The decreased expression of calcineurin B
(Ppp3r1) reduced the phosphorylation of PKD/PKCl and PKCd,
which is required for FceRI-induced mast cell degranulation. Calci-
neurin also regulates nuclear signals and gene transcription by
dephosphorylating the NFAT transcription factor allowing its
translocation into the nucleus. The knockdown of the regulatory
subunit Ppp3r1 decreased NFAT activation (44%), but was less
effective on NFkB activation (27%). In turn, knockdown of the cat-
alytic subunit PPP3CC did not change NFAT activation but increased
NFjB. These effects on the activity of transcription factors were
mirrored by changes in the release of cytokines. Thus, Ppp3r1
knockdown decreased secretion of TNFa, IL-13 and CCL-4, while
PPP3CC knockdown decreased TNFa, but increased IL-13 and
CCL-4 (Barbu et al. unpublished results). These results indicate that
in mast cells calcineurin controls both the FceRI-induced late cellu-
lar events by regulating the activity of transcription factors and
regulates degranulation by a mechanism that involves PKC .
The synthesis and secretion of cytokines after immune receptor
activation depends on NFAT and NFjB transcription factors. Mouse
mast cell lines that have NFAT or NFjB reporter systems were also
screened with this siRNA phosphatase library to determine mole-
cules that regulate late events after receptor stimulation (Zhang,
Barbu, Groves, and Siraganian unpublished observations). There
was no correlation in the effect of these siRNA on the NFAT, NFjB
or degranulation responses, suggesting that distinct phosphatases
regulate the FceRI-mediated early and late responses. Among the198 phosphatases, 16 consistently enhanced or inhibited the sig-
nals generated after FceRI-initiated NFAT or NFjB activation. The
positive hits were validated by testing in BMMC for their effects
on FceRI-induced degranulation and the release of the cytokines.
There were 12 hits that enhanced the NFAT or NFjB response;
all of these enhanced the release of at least one cytokine. Therefore,
these genes are positive regulators of the FceRI-induced late cellu-
lar responses. The largest increase was after the knockdown of
Inpp5d (SHIP-1), a known negative regulator of the FceRI pathway.
Among four hits that inhibited the activation of NFAT or NFjB,
three inhibited the receptor-induced cytokine generation and
two of these also the degranulation response. This strongly sug-
gests that these two molecules control FceRI-induced immediate
R.P. Siraganian et al. / FEBS Letters 584 (2010) 4933–4940 4939and late cellular events. These screens using degranulation, NFAT
or NFjB end-points have identiﬁed molecules not previously asso-
ciated with the FceRI pathway. Therefore, these methods allow
high throughput whole-genome RNAi screening to identify many
new molecules involved in the FceRI-mediated cellular responses.8. Caveats on interpreting signaling studies in mast cells
The early studies to identify cell signaling molecules used pro-
tein biochemical analysis of cells. The use of inhibitors also sug-
gested the role of certain enzyme classes although it was
complicated by the non-speciﬁcity of most such compounds. The
analysis of changes in molecules (e.g., phosphorylation of proteins)
suggested their involvement in the pathway without indicating
their exact role. The overexpression of the protein whether it
was the wild-type, constitutively active or dominant negative
was also used to analyze signal transduction, however, this was
complicated by the presence of the endogenously wild-type pro-
teins. The analysis of variants of cell lines as well as cells from
gene-knock-out mice then added a new dimension for the study
of the role of individual molecules in signal transduction. The
knock-out mice also allowed the analysis of the role of the gene
in the whole animal in vivo immune responses and allergic
reactions.
The use of bone marrow derived mast cells from gene targeted
mice can often provide useful information; however, the pheno-
type resulting from the deletion of a gene may not be due simply
to the loss of the function of the corresponding protein. There
can be compensatory effects by increased or decreased expression
of other molecules which become pronounced with prolonged loss
of the molecule. This would be more of a problem in long-term
experiments such as in BMMC, compared to the short-term knock-
down with siRNA. For example, in Lyn negative BMMC there is de-
creased expression of TRPC4 protein that may explain the delayed
calcium response of these cells [47]. Another complication is that
deletion of a gene can result in a developmental block and embry-
onic lethality (for example knock-out of the tyrosine kinase FAK).
Although in this case mast cells can be cultured from early em-
bryos, there are other genes that are required for cell maturation
and those cases require alternative strategies [48]. A secondary
problem is when a protein has several functions or domains then
the phenotypic consequences of gene knockout may manifest as
a combination of several different perturbations. For example, a
protein tyrosine kinase can function both as a positive and negative
regulator of signaling. The use of knock-ins with mutations or dele-
tions of parts of molecules can help in these signaling studies. The
absence of a protein could also result in compensatory increase in
other family members or changes in other proteins with which it
interacts. A problem is that there could be modifying genes, for
example the phenotype of gene deletion can vary depending on
the genetic background of the mice [49,50]. In these cases, gene
targeting with siRNA in a transient system might provide more
accurate insight into the function of the protein in the signaling
pathway.9. Concluding remarks
The availability of genomic sequences and the development of
new techniques have revolutionized the study of signal transduc-
tion. Gene targeting has allowed the introduction of mutations into
the mouse genome; including the knock-out of whole genes and
the knock-in of speciﬁc mutations in proteins. Whole genome se-
quences have also made possible the high-throughput use of siRNA
to test for the role of any expressed molecules in multiple signaling
pathways. Transient transfection with siRNA can also be a power-ful tool to unravel the relative function of different molecules in
signaling pathways. Data from these different techniques should
result in a better understanding of the signal transduction path-
ways in mast cells that are crucial for the release of different
inﬂammatory mediators. Such knowledge should lead to the devel-
opment of more effective pharmacological agents that modulate
these pathways.
Acknowledgments
We thank Jacqueline Groves for helpful discussions and review
of the manuscript; we also thank William Swaim for help with
morphological experiments. This work was supported by the Intra-
mural Research Program of the National Institutes of Health,
NIDCR.
References
[1] Kalesnikoff, J. and Galli, S.J. (2008) New developments in mast cell biology.
Nat. Immunol. 9, 1215–1223.
[2] Alvarez-Errico, D., Lessmann, E. and Rivera, J. (2009) Adapters in the
organization of mast cell signaling. Immunol. Rev. 232, 195–217.
[3] Metcalfe, D.D., Peavy, R.D. and Gilﬁllan, A.M. (2009) Mechanisms of mast cell
signaling in anaphylaxis. J. Allergy Clin. Immunol. 124, 639–646.
[4] Siraganian, R.P. (2003) Mast cell signal transduction from the high-afﬁnity IgE
receptor. Curr. Opin. Immunol. 15, 639–646.
[5] Zhang, J., Billingsley, M.L., Kincaid, R.L. and Siraganian, R.P. (2000)
Phosphorylation of Syk activation loop tyrosines is essential for Syk
function. An in vivo study using a speciﬁc anti-Syk activation loop
phosphotyrosine antibody. J. Biol. Chem. 275, 35442–35447.
[6] Benhamou, M., Ryba, N.J., Kihara, H., Nishikata, H. and Siraganian, R.P. (1993)
Protein-tyrosine kinase p72syk in high afﬁnity IgE receptor signaling.
Identiﬁcation as a component of pp72 and association with the receptor
gamma chain after receptor aggregation. J. Biol. Chem. 268, 23318–23324.
[7] Minoguchi, K., Benhamou, M., Swaim, W.D., Kawakami, Y., Kawakami, T. and
Siraganian, R.P. (1994) Activation of protein tyrosine kinase p72syk by FceRI
aggregation in rat basophilic leukemia cells. p72syk is a minor component but
the major protein tyrosine kinase of pp72. J. Biol. Chem. 269, 16902–16908.
[8] Hogan, P.G., Lewis, R.S. and Rao, A. (2010) Molecular basis of calcium signaling
in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28, 491–533.
[9] Vig, M. and Kinet, J.P. (2009) Calcium signaling in immune cells. Nat. Immunol.
10, 21–27.
[10] Hitomi, T., Zhang, J., Nicoletti, L.M., Grodzki, A.C., Jamur, M.C., Oliver, C. and
Siraganian, R.P. (2004) Phospholipase D1 regulates high-afﬁnity IgE receptor-
induced mast cell degranulation. Blood 104, 4122–4128.
[11] Kimura, T., Zhang, J., Sagawa, K., Sakaguchi, K., Appella, E. and Siraganian, R.P.
(1997) Syk-independent tyrosine phosphorylation and association of the
protein tyrosine phosphatases SHP-1 and SHP-2 with the high afﬁnity IgE
receptor. J. Immunol. 159, 4426–4434.
[12] Mocsai, A., Ruland, J. and Tybulewicz, V.L. (2010) The SYK tyrosine kinase: a
crucial player in diverse biological functions. Nat. Rev. Immunol. 10, 387–402.
[13] Siraganian, R.P., Zhang, J., Suzuki, K. and Sada, K. (2002) Protein tyrosine kinase
Syk in mast cell signaling. Mol. Immunol. 38, 1229–1233.
[14] Zhang, J., Berenstein, E.H., Evans, R.L. and Siraganian, R.P. (1996) Transfection
of Syk protein tyrosine kinase reconstitutes high afﬁnity IgE receptor-
mediated degranulation in a Syk-negative variant of rat basophilic leukemia
RBL-2H3 cells. J. Exp. Med. 184, 71–79.
[15] Grodzki, A.C., Moon, K.D., Berenstein, E.H. and Siraganian, R.P. (2009) FceRI-
induced activation by low antigen concentrations results in nuclear signals in
the absence of degranulation. Mol. Immunol. 46, 2539–2547.
[16] de Castro, R.O., Zhang, J., Jamur, M.C., Oliver, C. and Siraganian, R.P. (2010)
Tyrosines in the carboxy-terminus regulate Syk kinase activity and function. J.
Biol. Chem. 285, in press.
[17] Barbu, E.A., Zhang, J. and Siraganian, R.P. (2010) The limited contribution of
Fyn and Gab2 to the high afﬁnity IgE receptor signaling in mast cells. J. Biol.
Chem. 285, 15761–15768.
[18] Kimura, T., Kihara, H., Bhattacharyya, S., Sakamoto, H., Appella, E. and
Siraganian, R.P. (1996) Downstream signaling molecules bind to different
phosphorylated immunoreceptor tyrosine-based activation motif (ITAM)
peptides of the high afﬁnity IgE receptor. J. Biol. Chem. 271, 27962–27968.
[19] Chen, T. et al. (1996) Interaction of phosphorylated FceRIgamma
immunoglobulin receptor tyrosine activation motif-based peptides with
dual and single SH2 domains of p72syk. Assessment of binding parameters
and real time binding kinetics. J. Biol. Chem. 271, 25308–25315.
[20] Kihara, H. and Siraganian, R.P. (1994) Src homology 2 domains of Syk and Lyn
bind to tyrosine-phosphorylated subunits of the high afﬁnity IgE receptor. J.
Biol. Chem. 269, 22427–22432.
[21] Kimura, T., Sakamoto, H., Appella, E. and Siraganian, R.P. (1996)
Conformational changes induced in the protein tyrosine kinase p72syk by
tyrosine phosphorylation or by binding of phosphorylated immunoreceptor
tyrosine-based activation motif peptides. Mol. Cell. Biol. 16, 1471–1478.
4940 R.P. Siraganian et al. / FEBS Letters 584 (2010) 4933–4940[22] Deindl, S., Kadlecek, T.A., Brdicka, T., Cao, X., Weiss, A. and Kuriyan, J. (2007)
Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell
129, 735–746.
[23] Furlong, M.T., Mahrenholz, A.M., Kim, K.H., Ashendel, C.L., Harrison, M.L. and
Geahlen, R.L. (1997) Identiﬁcation of the major sites of autophosphorylation of
the murine protein-tyrosine kinase Syk. Biochim. Biophys. Acta 1355, 177–
190.
[24] Cao, L. et al. (2007) Quantitative time-resolved phosphoproteomic analysis of
mast cell signaling. J. Immunol. 179, 5864–5876.
[25] Zhang, Y., Oh, H., Burton, R.A., Burgner, J.W., Geahlen, R.L. and Post, C.B. (2008)
Tyr130 phosphorylation triggers Syk release from antigen receptor by long-
distance conformational uncoupling. Proc. Natl Acad. Sci. USA 105, 11760–
11765.
[26] Zhang, J., Berenstein, E. and Siraganian, R.P. (2002) Phosphorylation of Tyr342
in the linker region of Syk is critical for FceRI signaling in mast cells. Mol. Cell.
Biol. 22, 8144–8154.
[27] Latour, S., Zhang, J., Siraganian, R.P. and Veillette, A. (1998) A unique insert in
the linker domain of Syk is necessary for its function in immunoreceptor
signalling. EMBO J. 17, 2584–2595.
[28] Sada, K., Zhang, J. and Siraganian, R.P. (2000) Point mutation of a tyrosine in
the linker region of Syk results in a gain of function. J. Immunol. 164, 338–344.
[29] Paolini, R. et al. (2002) Activation of Syk tyrosine kinase is required for c-Cbl-
mediated ubiquitination of FceRI and Syk in RBL cells. J. Biol. Chem. 277,
36940–36947.
[30] Zhang, J., Chiang, Y.J., Hodes, R.J. and Siraganian, R.P. (2004) Inactivation of c-
Cbl or Cbl-b differentially affects signaling from the high afﬁnity IgE receptor.
J. Immunol. 173, 1811–1818.
[31] Zhang, J., Kimura, T. and Siraganian, R.P. (1998) Mutations in the activation
loop tyrosines of protein tyrosine kinase Syk abrogate intracellular signaling
but not kinase activity. J. Immunol. 161, 4366–4374.
[32] Kulathu, Y., Hobeika, E., Turchinovich, G. and Reth, M. (2008) The kinase Syk as
an adaptor controlling sustained calcium signalling and B-cell development.
EMBO J. 27, 1333–1344.
[33] Nishizumi, H. and Yamamoto, T. (1997) Impaired tyrosine phosphorylation
and Ca2+ mobilization, but not degranulation, in lyn-deﬁcient bone marrow-
derived mast cells. J. Immunol. 158, 2350–2355.
[34] Gomez, G., Gonzalez-Espinosa, C., Odom, S., Baez, G., Cid, M.E., Ryan, J.J. and
Rivera, J. (2005) Impaired FceRI-dependent gene expression and defective
eicosanoid and cytokine production as a consequence of Fyn deﬁciency in
mast cells. J. Immunol. 175, 7602–7610.
[35] Parravicini, V. et al. (2002) Fyn kinase initiates complementary signals required
for IgE-dependent mast cell degranulation. Nat. Immunol. 3, 741–748.[36] Xie, Z.H., Ambudkar, I. and Siraganian, R.P. (2002) The adapter molecule Gab2
regulates FceRI-mediated signal transduction in mast cells. J. Immunol. 168,
4682–4691.
[37] Gu, H. et al. (2001) Essential role for Gab2 in the allergic response. Nature 412,
186–190.
[38] Yu, M., Lowell, C.A., Neel, B.G. and Gu, H. (2006) Scaffolding adapter Grb2-
associated binder 2 requires Syk to transmit signals from FceRI. J. Immunol.
176, 2421–2429.
[39] Pfeiffer, J.R., Seagrave, J.C., Davis, B.H., Deanin, G.G. and Oliver, J.M. (1985)
Membrane and cytoskeletal changes associated with IgE-mediated serotonin
release from rat basophilic leukemia cells. J. Cell Biol. 101, 2145–2155.
[40] Apgar, J.R. (1991) Regulation of the antigen-induced F-actin response in rat
basophilic leukemia cells by protein kinase C. J. Cell Biol. 112, 1157–1163.
[41] Nishida, K. et al. (2005) FceRI-mediated mast cell degranulation requires
calcium-independent microtubule-dependent translocation of granules to the
plasma membrane. J. Cell Biol. 170, 115–126.
[42] Sahara, N., Siraganian, R.P. and Oliver, C. (1990) Morphological changes
induced by the calcium ionophore A23187 in rat basophilic leukemia (2H3)
cells. J. Histochem. Cytochem. 38, 975–983.
[43] Okazaki, H., Zhang, J., Hamawy, M.M. and Siraganian, R.P. (1997) Activation of
protein-tyrosine kinase Pyk2 is downstream of Syk in FceRI signaling. J. Biol.
Chem. 272, 32443–32447.
[44] Benhamou, M., Gutkind, J.S., Robbins, K.C. and Siraganian, R.P. (1990) Tyrosine
phosphorylation coupled to IgE receptor-mediated signal transduction and
histamine release. Proc. Natl Acad. Sci. USA 87, 5327–5330.
[45] Benhamou, M. and Siraganian, R.P. (1992) Protein-tyrosine phosphorylation:
an essential component of FceRI signaling. Immunol. Today 13, 195–197.
[46] Zhang, J., Mendoza, M., Guiraldelli, M.F., Barbu, E.A. and Siraganian, R.P. (2010)
Small interfering RNA screen for phosphatases involved in IgE-mediated mast
cell degranulation. J. Immunol. 184, 7178–7185.
[47] Hernandez-Hansen, V. et al. (2004) Dysregulated FceRI signaling and altered
Fyn and SHIP activities in Lyn-deﬁcient mast cells. J. Immunol. 173, 100–112.
[48] Vial, D., Oliver, C., Jamur, M.C., Pastor, M.V., da Silva Trindade, E., Berenstein, E.,
Zhang, J. and Siraganian, R.P. (2003) Alterations in granule matrix and cell
surface of focal adhesion kinase-deﬁcient mast cells. J. Immunol. 171, 6178–
6186.
[49] Kambayashi, T., Larosa, D.F., Silverman, M.A. and Koretzky, G.A. (2009)
Cooperation of adapter molecules in proximal signaling cascades during
allergic inﬂammation. Immunol. Rev. 232, 99–114.
[50] Yamashita, Y. et al. (2007) Genetic variation inﬂuences FceRI-induced mast
cell activation and allergic responses. J. Immunol. 179, 740–743.
